Marshall Wace’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-161,222
| Closed | -$13.7M | – | 2405 |
|
|
2020
Q3 | $13.7M | Buy |
161,222
+32,770
| +26% | +$1.66M | 0.09% | 234 |
|
|
2020
Q2 | $4.55M | Buy |
+128,452
| New | +$3.76M | 0.03% | 500 |
|
|
2020
Q1 | – | Sell |
-297,513
| Closed | -$6.29M | – | 2259 |
|
|
2019
Q4 | $6.29M | Sell |
297,513
-206,695
| -41% | -$3.65M | 0.04% | 454 |
|
|
2019
Q3 | $6.69M | Sell |
504,208
-97,908
| -16% | -$1.44M | 0.05% | 412 |
|
|
2019
Q2 | $8.35M | Buy |
+602,116
| New | +$9.06M | 0.07% | 331 |
|
|
2019
Q1 | – | Sell |
-279,917
| Closed | -$3.99M | – | 2199 |
|
|
2018
Q4 | $3.99M | Buy |
+279,917
| New | +$5.56M | 0.04% | 517 |
|
|
2018
Q2 | – | Sell |
-11,800
| Closed | -$172K | – | 897 |
|
|
2018
Q1 | $172K | Buy |
+11,800
| New | +$193K | 0.01% | 526 |
|
|
2016
Q1 | – | Sell |
-857,062
| Closed | -$2.63M | – | 1252 |
|
|
2015
Q4 | $2.63M | Buy |
+857,062
| New | +$2.39M | 0.02% | 504 |
|
Marshall Wace's IMMU Position: Q4 2020 in Review
Marshall Wace sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 161,222 shares — an estimated $13.7M sold.
Marshall Wace first reported a position in IMMU in Q4 2015 and held it in 8 quarters. The position peaked at $13.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Marshall Wace reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Marshall Wace sold 161,222 Immunomedics Inc shares in Q4 2020, an estimated $13.7M.
- Marshall Wace first reported a position in Immunomedics Inc in Q4 2015 and held it in 8 quarters.
- Marshall Wace's Immunomedics Inc position peaked at $13.7M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.